Medical Journals

Prostaglandins Enhance Epidermal Growth Factor-induced Dna Synthesis in Hepatocytes by Stimulation of E Prostanoid 3 and F Prostanoid Receptors.

Authors:
  • Meisdalen Kristin
  • Dajani Olav F
  • Christoffersen Thoralf
  • Sandnes Dagny

From: Department of Pharmacology, Faculty of Medicine, University of Oslo, P.O. Box 1057 Blindern, N-0316 Oslo, Norway. k.b.meisdalen@medisin.uio.no

The Journal of pharmacology and experimental therapeutics

  • Publish Date: Sep 2007
  • ISSN: 0022-3565
  • Volume: 322
  • Issue: 3
  • Pages: 1044-50
  • Medium: Print
  • Language: English
  • Citation (JAMA): Meisdalen Kristin, Dajani Olav F, Christoffersen Thoralf, et al. Prostaglandins Enhance Epidermal Growth Factor-induced Dna Synthesis in Hepatocytes by Stimulation of E Prostanoid 3 and F Prostanoid Receptors.. J. Pharmacol. Exp. Ther. Sep 2007;322:1044-50

Abstract

Prostaglandins stimulate hepatocyte proliferation in vivo and in vitro. We have examined the role of E prostanoid (EP) and F prostanoid receptors (FP) in enhancing the growth-stimulatory effect of epidermal growth factor (EGF) in cultured hepatocytes. The EP2 receptor agonist butaprost had no significant effect on EGF-induced DNA synthesis. EP1 receptor-selective antagonists did not affect the enhancement by prostaglandin E(2) of EGF-stimulated DNA synthesis. Sulprostone, misoprostol, and fluprostenol strongly enhanced DNA synthesis and inhibited glucagon-stimulated cAMP accumulation, indicating that they all activated EP3 receptors. Sulprostone and fluprostenol, and to a lesser extent misoprostol, stimulated accumulation of inositol phosphates. The effects of fluprostenol and sulprostone on phospholipase C (PLC) were inhibited by the FP receptor antagonist AL-8810 [9 alpha, 15R-dihydroxy-11 beta-fluoro-15-(2,3-dihydro-1H-inden-2-yl)-16,17,18,19,20-pentanor-prosta-5Z, 13E-dien-1-oic acid], indicating that this effect was mediated by FP receptors. Inhibition of protein kinase C with GF109203X [2-[1-(3-dimetylaminopropyl)-1H-indol-3-yl]-maleimide] resulted in a partial reduction of the growth stimulation induced by fluprostenol, indicating a minor role of FP receptors. Combining fluprostenol with misoprostol, but not with sulprostone, resulted in partially additive effects on DNA synthesis, suggesting that both EP3 and FP receptors are involved. Combining sulprostone with misoprostol did not result in additive effects on DNA synthesis, suggesting that EP4 receptors were not involved. We conclude that, although a minor effect is exerted by FP receptors, the growth-stimulatory effects of prostaglandins in rat hepatocytes are mediated mainly by EP3 receptors. We have found no evidence of EP1 receptor involvement.

Mesh Headings (Keywords): Animals, Cell Proliferation, Cells, Cultured, DNA, Epidermal Growth Factor, Hepatocytes, Prostaglandins, Rats, Receptors, Prostaglandin, Receptors, Prostaglandin E


Check for Full Text / PubMed Unique Identifier (PMID): 17567965


This abstract is part of PubMed, a service of the U.S. National Library of Medicine. PubMed includes more than 17 million citations from MEDLINE and other life science journals for biomedical articles. See Copyright and Disclaimers.

Linked medical terms appearing on this page are added by Healia to help readers find more information and are not part of the original PubMed document.

The data herein was last updated on July 8th, 2008 and may not reflect the most current and accurate data available from NLM.


Advertisements

About | Privacy Policy | Business Solutions | Advertise | Contact | Add Healia to your site

©2012. Healia / Meredith Corporation  

Use of this site constitutes acceptance of our Terms of Service and Privacy Policy. All content on this Web site, including medical opinion and any other health-related information, is for informational purposes only and should not be used for a specific diagnosis or individual treatment plan for any situation. Use of this site and the information contained herein does not create a doctor-patient relationship. Always seek the direct advice of your doctor in connection with any questions or issues you may have regarding your own health or the health of others.